Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prediction of the mechanism of Jin Ling Zi Powder  in the intervention of gastric cancer based on transcriptomics and network pharmacology

View through CrossRef
Abstract Background Traditional Chinese medicine (TCM) has unique advantages in alleviating gastric cancer (GC), and Jin Ling Zi Powder is a common drug used in TCM treatment. However, the potential mechanism for its treatment of GC is unclear. Objective The purpose of this study is to integrate transcriptomics, network pharmacology and molecular docking to investigate the active components and targets of Jin Ling Zi Powder's intervention in GC and related pathways, in order to provide a basis for further revealing its mechanism of action and developing Jin Ling Zi Powder. Methods The potential targets of Jin Ling Zi Powder and GC-related genes were obtained from public database. Potential targets and signaling pathways were identified and visualized through bioinformatics analysis, including protein-protein interaction (PPI), Gene Ontology (GO) functional enrichment analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.Subsequently, molecular docking was performed to further validate these findings. Results The results showed that potential targets including IL6, PTGS2, MMP9, HMOX1, MYC, CHRM3, TOP2A, CA2, and KCNMA1 were the therapeutic targets of Jin Ling Zi Powder for gastric cancer. The functional enrichment analysis indicate that through synergistically regulating some biological pathway, such as inflammatory response, cellular response to tumor necrosis factor, AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, TNF signaling pathway, MicroRNAs in cancer, Pathways in cancer, etc., which have therapeutic effects on gastric cancer. In addition, the molecular docking results showed that the compounds had good binding activity to the action target in vivo. Conclusion This study comprehensively describes the potential targets and molecular mechanisms of Jin Ling Zi Powder for the treatment of gastric cancer. It also provides promising avenues for revealing the treatment of diseases by TCM through scientific basis and therapeutic mechanisms.
Springer Science and Business Media LLC
Title: Prediction of the mechanism of Jin Ling Zi Powder  in the intervention of gastric cancer based on transcriptomics and network pharmacology
Description:
Abstract Background Traditional Chinese medicine (TCM) has unique advantages in alleviating gastric cancer (GC), and Jin Ling Zi Powder is a common drug used in TCM treatment.
However, the potential mechanism for its treatment of GC is unclear.
Objective The purpose of this study is to integrate transcriptomics, network pharmacology and molecular docking to investigate the active components and targets of Jin Ling Zi Powder's intervention in GC and related pathways, in order to provide a basis for further revealing its mechanism of action and developing Jin Ling Zi Powder.
Methods The potential targets of Jin Ling Zi Powder and GC-related genes were obtained from public database.
Potential targets and signaling pathways were identified and visualized through bioinformatics analysis, including protein-protein interaction (PPI), Gene Ontology (GO) functional enrichment analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
Subsequently, molecular docking was performed to further validate these findings.
Results The results showed that potential targets including IL6, PTGS2, MMP9, HMOX1, MYC, CHRM3, TOP2A, CA2, and KCNMA1 were the therapeutic targets of Jin Ling Zi Powder for gastric cancer.
The functional enrichment analysis indicate that through synergistically regulating some biological pathway, such as inflammatory response, cellular response to tumor necrosis factor, AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, TNF signaling pathway, MicroRNAs in cancer, Pathways in cancer, etc.
, which have therapeutic effects on gastric cancer.
In addition, the molecular docking results showed that the compounds had good binding activity to the action target in vivo.
Conclusion This study comprehensively describes the potential targets and molecular mechanisms of Jin Ling Zi Powder for the treatment of gastric cancer.
It also provides promising avenues for revealing the treatment of diseases by TCM through scientific basis and therapeutic mechanisms.

Related Results

Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract Introduction Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
4060 Background: Gastric cancer is one of the most common cancer types. Most patients were diagnosed at advanced stages and experienced poor prognosis. A non-invasive assay for th...
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
<div>Abstract<p>The hyaluronan-mediated motility receptor (HMMR) is overexpressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing ...
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
<div>Abstract<p>The hyaluronan-mediated motility receptor (HMMR) is overexpressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing ...
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract Background: The associations of multiple autoimmune conditions with gastric cancer may reflect their co-occurrence with autoimmune gastritis and its clinica...
Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer
Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer
We reported that Rev-erbα, a transcriptional repressor, is reduced in human gastric cancer and that it inhibits glycolysis in cultured gastric cancer cells. However, it is unclear ...
Long-term proton pump inhibitor use and the incidence of gastric cancer: A systematic review and meta-analysis
Long-term proton pump inhibitor use and the incidence of gastric cancer: A systematic review and meta-analysis
Background: There are controverted whether the long-term use of proton pump inhibitors (PPI) will increase the risk of gastric cancer. We performed a meta-analysis to assess the ri...
Data from NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression
Data from NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression
<div>Abstract<p>Gastric cancer is an aggressive malignancy with poor patient outcomes. N-Acetyltransferase 10 (NAT10) is an acetyltransferase that has been reported to ...

Back to Top